University of Michigan researchers said Sunday they have created a line of human embryonic stem cells that will spur the state’s medical research industry. The cell line, known as UM4-6, was developed under a 2008 program approved by Michigan voters that allows the development of stem cells from unused human embryos obtained from fertility clinics.
Recent Posts
- Ketogenic Diet Enhances CAR-T Cancer Therapy
- Socioeconomic Barriers Limit Access to Lifesaving Stem Cell Transplants in AML
- Newly discovered mechanism in the cell’s energy factory can lead to new treatment of muscle disorders
- New drug tested to reduce side effect of ‘half-matched’ stem cell transplants
- Gene and Cell Therapies Take Aim at Parkinson’s Disease
- Health Net grant for UC Davis Stem Cell Program to improve access to CAR T-cell therapy